Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Quoin Pharmaceuticals, Ltd. QNRX
$0.50
+$0.02 (3.20%)
На 18:04, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
5687553.00000000
-
week52high
28.11
-
week52low
0.43
-
Revenue
0
-
P/E TTM
0
-
Beta
0.00000000
-
EPS
-3.78000000
-
Last Dividend
0.00000000
-
Next Earnings Date
08 мая 2023 г. в 20:00
Описание компании
Quoin Pharmaceuticals, Ltd., a clinical stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases. Its lead product is QRX003, a topical lotion to treat Netherton Syndrome. The company also offers three other pipeline products in development, which are also targeting rare skin diseases, including epidermolysis bullosa, Netherton Syndrome, and Scleroderma. Quoin Pharmaceuticals, Ltd. was incorporated in 2018 and is based in Ashburn, Virginia.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Ladenburg Thalmann | Buy | 06 мая 2022 г. | |
| Maxim Group | Buy | 07 янв 2022 г. | |
| JMP Securities | Market Outperform | 15 дек 2021 г. | |
| Alliance Global Partners | Buy | 07 сент 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
Quoin Pharmaceuticals, Ltd. (QNRX) Q3 2022 Earnings Call Transcript
Seeking Alpha
10 ноя 2022 г. в 14:38
Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX ) Q3 2022 Earnings Conference Call November 10, 2022 10:00 AM ET Company Participants Gordon Dunn - CFO Michael Myers - CEO Conference Call Participants Aydin Huseynov - Ladenburg Thalmann James Molloy - Alliance Global Partners Naz Rahman - Maxim Group Operator Good morning and welcome to the Quoin Pharmaceuticals Limited Third Quarter Financial Results and Business Update Call.
Quoin Pharmaceuticals to Report Third Quarter 2022 Financial Results and Provide Corporate Update on November 10th
GlobeNewsWire
01 ноя 2022 г. в 08:30
ASHBURN, Va., Nov. 01, 2022 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a clinical stage, specialty pharmaceutical company focused on rare and orphan diseases, announced today that its third quarter 2022 financial results will be reported on Thursday, November 10, 2022 before the open of the financial markets. Management will also host a webcast and conference call on November 10, 2022 at 8:30 a.m. ET to discuss the results and provide a corporate update.
10 Top Penny Stocks To Buy According To Wall Street Analysts In 2022
PennyStocks
19 окт 2022 г. в 14:12
Penny stocks to buy according to analysts in 2022. The post 10 Top Penny Stocks To Buy According To Wall Street Analysts In 2022 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
7 Penny Stocks To Buy According To Top Wall Street Analysts
PennyStocks
18 окт 2022 г. в 14:52
Penny stocks to buy according to analysts in 2022. The post 7 Penny Stocks To Buy According To Top Wall Street Analysts appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Hot Penny Stocks To Watch Today As Stock Market Crash Continues
PennyStocks
20 сент 2022 г. в 11:50
Hot penny stocks to watch today. The post Hot Penny Stocks To Watch Today As Stock Market Crash Continues appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.